PublishedMarch 5, 2026 Category Partner News Avalyn Announces First Patient Dosed in AURA Phase 2 Clinical Trial Evaluating AP02, Inhaled Nintedanib, for the Treatment of Idiopathic Pulmonary Fibrosis
PublishedDecember 16, 2025 Categories eFlow Integrated PARI Publications The Importance of Mesh Nebulizer Configuration in mRNA-LNP Delivery Performance
PublishedDecember 2, 2025 Categories PARI News Partner News Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Delivered Via the Proprietary eFlow® Nebulizer System
PublishedNovember 27, 2025 Categories eFlow Integrated PARI Publications Effect of Nebulizer Breath-Guiding on Breathing Patterns